- Stocks
- Pharma & Healthcare
- KHFM HOSPITALIT
KHFM HOSPITALIT share price
NSE: KHFMPharma & Healthcare
KHFM HOSPITALIT at a glance
KHFM HOSPITALIT (NSE: KHFM) closed at ₹40.90 on 15 Oct 2026. With a market capitalisation of ₹95 Cr, it ranks 2700th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector.
Its return on equity was 5.2% in FY26. Over the past year the share price has fallen 50.1%. Its 52-week range is ₹39.00 (14 Oct 2026) to ₹82.95 (28 Oct 2025); the last close is 50.7% below the high. Promoters held 37.17% of the company as of 31 Mar 2026.
Key numbers
- Market cap
- ₹95 CrRank 2700 on NSE
- Price to book
- 1.83×FY26
- ROE
- 5.2%FY26
- ROCE
- 13.3%FY26
- Debt to equity
- 0.52FY26
- Net profit margin
- 3.2%FY26
- Book value / share
- ₹29.22FY26
- 52-week high
- ₹82.9528 Oct 2025
- 52-week low
- ₹39.0014 Oct 2026
- 1-year return
- −50.1%
- RSI (14-day)
- 43.4
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +4.87% | +2.1% | −9.0% | −36.0% | −50.1% |
KHFM HOSPITALIT financials
| Item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹90 Cr | ₹112 Cr | ₹104 Cr | ₹107 Cr |
| Operating profit | ₹3 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr |
| Net profit | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| EPS (₹) | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Cash from operations | −₹16 Cr | ₹7 Cr | −₹3 Cr | −₹6 Cr |
| Total debt | ₹12 Cr | ₹8 Cr | ₹5 Cr | ₹0 Cr |
| Shareholders' equity | ₹44 Cr | ₹47 Cr | ₹58 Cr | ₹68 Cr |
KHFM HOSPITALIT shareholding pattern
| Holder | 2 May 2024 | 30 Sep 2024 | 31 Mar 2025 | 30 Sep 2025 | 12 Nov 2025 | 31 Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 37.03% | 37.03% | 37.03% | 35.86% | 37.17% | 37.17% |
| Non-institutions | 62.97% | 62.97% | 62.97% | 64.14% | 62.83% | 62.83% |
KHFM HOSPITALIT vs peers
The listed Pharma & Healthcare companies nearest to KHFM HOSPITALIT by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| MERCURYLABMercury Labs | — | — | — | ₹102 Cr | — | — |
| VAISHALIVaishali Pharma | ₹7.49 | +2.04% | −30.3% | ₹101 Cr | 124.8 | — |
| CONCORDConcord Drugs | — | — | — | ₹101 Cr | — | — |
| DENISCHEMDenis Chem Lab | — | — | — | ₹101 Cr | — | — |
| FORTISMLRFortis Malar | — | — | — | ₹97 Cr | — | — |
| RAAJMEDIRaaj Medisafe | — | — | — | ₹97 Cr | — | — |
| KHFMKHFM HOSPITALIT | ₹40.90 | +4.87% | −50.1% | ₹95 Cr | — | — |
Ask anything about KHFM HOSPITALIT
Pivot answers on the live chart with evidence you can check, and tests strategies against KHFM's own history. Try: “Why has KHFM moved over the last three months?” · “Backtest a 50-day moving-average crossover on KHFM over five years” · “Compare KHFM with MERCURYLAB on margins and valuation”
Frequently asked questions about KHFM HOSPITALIT
What is the share price of KHFM HOSPITALIT today?
KHFM HOSPITALIT (NSE: KHFM) last closed at ₹40.90 on 15 Oct 2026. Its 52-week high is ₹82.95 and its 52-week low is ₹39.00.
What is the market cap of KHFM HOSPITALIT?
KHFM HOSPITALIT's market capitalisation is ₹95 Cr (₹95 Cr) at the 22 Oct 2026 close, ranking 2700th among the NSE companies Pivot tracks.
What is the ROE and ROCE of KHFM HOSPITALIT?
Return on equity was 5.2% in FY26 and return on capital employed was 13.3% in FY26 (consolidated figures).
Is KHFM HOSPITALIT a debt-free company?
No. KHFM HOSPITALIT's debt-to-equity ratio was 0.52 in FY26, with total debt of ₹0 Cr.
How has KHFM HOSPITALIT stock performed over the last year?
KHFM HOSPITALIT's share price has fallen 50.1% over the past year, −36.0% over three months and −9.0% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of KHFM HOSPITALIT?
As of 31 Mar 2026: promoters 37.17%, non-institutions 62.83%.
Who are KHFM HOSPITALIT's competitors?
The listed Pharma & Healthcare companies closest to KHFM HOSPITALIT by market cap are Mercury Labs, Vaishali Pharma, Concord Drugs, Denis Chem Lab, Fortis Malar and Raaj Medisafe.
Is KHFM HOSPITALIT a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out KHFM HOSPITALIT's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KHFM against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 15 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with K · all NSE stocks · this page as text